Pfizer signs deal to manufacture and supply Gilead's remdesivir for COVID-19 treatment - Moneycontrol

The US drugmaker would provide contract manufacturing services at its facility in Kansas to produce the drug.

Pfizer Inc said on Friday it signed a multi-year agreement with Gilead Sciences Inc to manufacture and supply the company's antiviral drug remdesivir for COVID-19 patients.

The US drugmaker would provide contract manufacturing services at its facility in Kansas to produce the drug.

 

First Published on Aug 7, 2020 06:07 pm

Let's block ads! (Why?)

Read Again https://www.moneycontrol.com/news/trends/health-trends/pfizer-signs-deal-to-manufacture-and-supply-gileads-remdesivir-for-covid-19-treatment-5661431.html

Bagikan Berita Ini